Superworth

Vanda Pharmaceuticals EPS VNDA

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Sep 30, 2026
−$4.62
Latest quarter, Q3 FY26
−$0.37
Fiscal year 2025
−$3.73

Vanda Pharmaceuticals' earnings per share was −$4.62 over the twelve months to Sep 30, 2026.

In its latest quarter, Q3 FY26, it was −$0.37.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.73n/a
FY2024−$0.32−740%
FY2023$0.05−58%
FY2022$0.12−79%
FY2021$0.58+35%
FY2020$0.43−80%
FY2019$2.12+351%
FY2018$0.47n/a
FY2017−$0.34n/a
FY2016−$0.42n/a
FY2015−$0.94−413%
FY2014$0.30n/a
FY2013−$0.68n/a
FY2012−$0.98n/a
FY2011−$0.36n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26−$0.37n/a−$4.62
Q2 FY26−$1.04n/a−$4.63
Q1 FY26−$0.82n/a−$4.05
Q4 FY25−$2.39n/a−$3.73
Q3 FY25−$0.38n/a−$1.42
Q2 FY25−$0.46n/a−$1.13
Q1 FY25−$0.50n/a−$0.75
Q4 FY24−$0.08n/a−$0.32
Q3 FY24−$0.09n/a−$0.28
Q2 FY24−$0.08−367%−$0.19
Q1 FY24−$0.07−217%−$0.08
Q4 FY23−$0.04−133%$0.05

Against its peers

Companies in Drug Manufacturers - General nearest Vanda Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
VNDAVanda Pharmaceuticals−$4.62
NATRNatures Sunshine Products$1.01+36% a year
CRMDCorMedix$2.13+184% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
LFVNLifevantage$0.40−46% a year
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
SPROSpero Therapeutics$0.11
Peer median$0.78

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Vanda Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.